Global Long-acting Hormone Injection Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Long-acting Hormone Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Long-acting Hormone Injection Industry Forecast” looks at past sales and reviews total world Long-acting Hormone Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Long-acting Hormone Injection sales for 2024 through 2030. With Long-acting Hormone Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting Hormone Injection industry.
This Insight Report provides a comprehensive analysis of the global Long-acting Hormone Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-acting Hormone Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting Hormone Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting Hormone Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting Hormone Injection.
United States market for Long-acting Hormone Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Long-acting Hormone Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Long-acting Hormone Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Long-acting Hormone Injection players cover Pfizer, Bayer, Organon, Merck & Co. Inc., Adare Pharma Solutions, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting Hormone Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Long-acting Hormone Injection market?
What factors are driving Long-acting Hormone Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-acting Hormone Injection market opportunities vary by end market size?
How does Long-acting Hormone Injection break out by Type, by Application?
The global Long-acting Hormone Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Long-acting Hormone Injection Industry Forecast” looks at past sales and reviews total world Long-acting Hormone Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Long-acting Hormone Injection sales for 2024 through 2030. With Long-acting Hormone Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting Hormone Injection industry.
This Insight Report provides a comprehensive analysis of the global Long-acting Hormone Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-acting Hormone Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting Hormone Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting Hormone Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting Hormone Injection.
United States market for Long-acting Hormone Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Long-acting Hormone Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Long-acting Hormone Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Long-acting Hormone Injection players cover Pfizer, Bayer, Organon, Merck & Co. Inc., Adare Pharma Solutions, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting Hormone Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Long-acting Contraceptive Injection
- Growth Hormone Injection
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Bayer
- Organon
- Merck & Co. Inc.
- Adare Pharma Solutions
- Mylan NV
- Novo Nordisk
- Genentech
- Eli Lily
- Shree Venkatesh International Limited
- LG Chem
- Anhui Anke Biotechnology
- Zhongshan Sinobioway Hygene Biomedicine
- Shanghai United Cell Biotechnology
- Changchun GeneScience Pharmaceutical
What is the 10-year outlook for the global Long-acting Hormone Injection market?
What factors are driving Long-acting Hormone Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-acting Hormone Injection market opportunities vary by end market size?
How does Long-acting Hormone Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting Hormone Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Long-acting Hormone Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Long-acting Hormone Injection by Country/Region, 2019, 2023 & 2030
2.2 Long-acting Hormone Injection Segment by Type
2.2.1 Long-acting Contraceptive Injection
2.2.2 Growth Hormone Injection
2.2.3 Others
2.3 Long-acting Hormone Injection Sales by Type
2.3.1 Global Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Long-acting Hormone Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Long-acting Hormone Injection Sale Price by Type (2019-2024)
2.4 Long-acting Hormone Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Long-acting Hormone Injection Sales by Application
2.5.1 Global Long-acting Hormone Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Long-acting Hormone Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Long-acting Hormone Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Long-acting Hormone Injection Breakdown Data by Company
3.1.1 Global Long-acting Hormone Injection Annual Sales by Company (2019-2024)
3.1.2 Global Long-acting Hormone Injection Sales Market Share by Company (2019-2024)
3.2 Global Long-acting Hormone Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Long-acting Hormone Injection Revenue by Company (2019-2024)
3.2.2 Global Long-acting Hormone Injection Revenue Market Share by Company (2019-2024)
3.3 Global Long-acting Hormone Injection Sale Price by Company
3.4 Key Manufacturers Long-acting Hormone Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting Hormone Injection Product Location Distribution
3.4.2 Players Long-acting Hormone Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING HORMONE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Long-acting Hormone Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Long-acting Hormone Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Long-acting Hormone Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Long-acting Hormone Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Long-acting Hormone Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Long-acting Hormone Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Long-acting Hormone Injection Sales Growth
4.4 APAC Long-acting Hormone Injection Sales Growth
4.5 Europe Long-acting Hormone Injection Sales Growth
4.6 Middle East & Africa Long-acting Hormone Injection Sales Growth
5 AMERICAS
5.1 Americas Long-acting Hormone Injection Sales by Country
5.1.1 Americas Long-acting Hormone Injection Sales by Country (2019-2024)
5.1.2 Americas Long-acting Hormone Injection Revenue by Country (2019-2024)
5.2 Americas Long-acting Hormone Injection Sales by Type (2019-2024)
5.3 Americas Long-acting Hormone Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting Hormone Injection Sales by Region
6.1.1 APAC Long-acting Hormone Injection Sales by Region (2019-2024)
6.1.2 APAC Long-acting Hormone Injection Revenue by Region (2019-2024)
6.2 APAC Long-acting Hormone Injection Sales by Type (2019-2024)
6.3 APAC Long-acting Hormone Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting Hormone Injection by Country
7.1.1 Europe Long-acting Hormone Injection Sales by Country (2019-2024)
7.1.2 Europe Long-acting Hormone Injection Revenue by Country (2019-2024)
7.2 Europe Long-acting Hormone Injection Sales by Type (2019-2024)
7.3 Europe Long-acting Hormone Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting Hormone Injection by Country
8.1.1 Middle East & Africa Long-acting Hormone Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Long-acting Hormone Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Long-acting Hormone Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Long-acting Hormone Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting Hormone Injection
10.3 Manufacturing Process Analysis of Long-acting Hormone Injection
10.4 Industry Chain Structure of Long-acting Hormone Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting Hormone Injection Distributors
11.3 Long-acting Hormone Injection Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING HORMONE INJECTION BY GEOGRAPHIC REGION
12.1 Global Long-acting Hormone Injection Market Size Forecast by Region
12.1.1 Global Long-acting Hormone Injection Forecast by Region (2025-2030)
12.1.2 Global Long-acting Hormone Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Long-acting Hormone Injection Forecast by Type (2025-2030)
12.7 Global Long-acting Hormone Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Long-acting Hormone Injection Product Portfolios and Specifications
13.1.3 Pfizer Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Long-acting Hormone Injection Product Portfolios and Specifications
13.2.3 Bayer Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Organon
13.3.1 Organon Company Information
13.3.2 Organon Long-acting Hormone Injection Product Portfolios and Specifications
13.3.3 Organon Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Organon Main Business Overview
13.3.5 Organon Latest Developments
13.4 Merck & Co. Inc.
13.4.1 Merck & Co. Inc. Company Information
13.4.2 Merck & Co. Inc. Long-acting Hormone Injection Product Portfolios and Specifications
13.4.3 Merck & Co. Inc. Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck & Co. Inc. Main Business Overview
13.4.5 Merck & Co. Inc. Latest Developments
13.5 Adare Pharma Solutions
13.5.1 Adare Pharma Solutions Company Information
13.5.2 Adare Pharma Solutions Long-acting Hormone Injection Product Portfolios and Specifications
13.5.3 Adare Pharma Solutions Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Adare Pharma Solutions Main Business Overview
13.5.5 Adare Pharma Solutions Latest Developments
13.6 Mylan NV
13.6.1 Mylan NV Company Information
13.6.2 Mylan NV Long-acting Hormone Injection Product Portfolios and Specifications
13.6.3 Mylan NV Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Mylan NV Main Business Overview
13.6.5 Mylan NV Latest Developments
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Information
13.7.2 Novo Nordisk Long-acting Hormone Injection Product Portfolios and Specifications
13.7.3 Novo Nordisk Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Novo Nordisk Main Business Overview
13.7.5 Novo Nordisk Latest Developments
13.8 Genentech
13.8.1 Genentech Company Information
13.8.2 Genentech Long-acting Hormone Injection Product Portfolios and Specifications
13.8.3 Genentech Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Genentech Main Business Overview
13.8.5 Genentech Latest Developments
13.9 Eli Lily
13.9.1 Eli Lily Company Information
13.9.2 Eli Lily Long-acting Hormone Injection Product Portfolios and Specifications
13.9.3 Eli Lily Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Eli Lily Main Business Overview
13.9.5 Eli Lily Latest Developments
13.10 Shree Venkatesh International Limited
13.10.1 Shree Venkatesh International Limited Company Information
13.10.2 Shree Venkatesh International Limited Long-acting Hormone Injection Product Portfolios and Specifications
13.10.3 Shree Venkatesh International Limited Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Shree Venkatesh International Limited Main Business Overview
13.10.5 Shree Venkatesh International Limited Latest Developments
13.11 LG Chem
13.11.1 LG Chem Company Information
13.11.2 LG Chem Long-acting Hormone Injection Product Portfolios and Specifications
13.11.3 LG Chem Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 LG Chem Main Business Overview
13.11.5 LG Chem Latest Developments
13.12 Anhui Anke Biotechnology
13.12.1 Anhui Anke Biotechnology Company Information
13.12.2 Anhui Anke Biotechnology Long-acting Hormone Injection Product Portfolios and Specifications
13.12.3 Anhui Anke Biotechnology Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Anhui Anke Biotechnology Main Business Overview
13.12.5 Anhui Anke Biotechnology Latest Developments
13.13 Zhongshan Sinobioway Hygene Biomedicine
13.13.1 Zhongshan Sinobioway Hygene Biomedicine Company Information
13.13.2 Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Portfolios and Specifications
13.13.3 Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Zhongshan Sinobioway Hygene Biomedicine Main Business Overview
13.13.5 Zhongshan Sinobioway Hygene Biomedicine Latest Developments
13.14 Shanghai United Cell Biotechnology
13.14.1 Shanghai United Cell Biotechnology Company Information
13.14.2 Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Portfolios and Specifications
13.14.3 Shanghai United Cell Biotechnology Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Shanghai United Cell Biotechnology Main Business Overview
13.14.5 Shanghai United Cell Biotechnology Latest Developments
13.15 Changchun GeneScience Pharmaceutical
13.15.1 Changchun GeneScience Pharmaceutical Company Information
13.15.2 Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Portfolios and Specifications
13.15.3 Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Changchun GeneScience Pharmaceutical Main Business Overview
13.15.5 Changchun GeneScience Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting Hormone Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Long-acting Hormone Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Long-acting Hormone Injection by Country/Region, 2019, 2023 & 2030
2.2 Long-acting Hormone Injection Segment by Type
2.2.1 Long-acting Contraceptive Injection
2.2.2 Growth Hormone Injection
2.2.3 Others
2.3 Long-acting Hormone Injection Sales by Type
2.3.1 Global Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Long-acting Hormone Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Long-acting Hormone Injection Sale Price by Type (2019-2024)
2.4 Long-acting Hormone Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Long-acting Hormone Injection Sales by Application
2.5.1 Global Long-acting Hormone Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Long-acting Hormone Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Long-acting Hormone Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Long-acting Hormone Injection Breakdown Data by Company
3.1.1 Global Long-acting Hormone Injection Annual Sales by Company (2019-2024)
3.1.2 Global Long-acting Hormone Injection Sales Market Share by Company (2019-2024)
3.2 Global Long-acting Hormone Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Long-acting Hormone Injection Revenue by Company (2019-2024)
3.2.2 Global Long-acting Hormone Injection Revenue Market Share by Company (2019-2024)
3.3 Global Long-acting Hormone Injection Sale Price by Company
3.4 Key Manufacturers Long-acting Hormone Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting Hormone Injection Product Location Distribution
3.4.2 Players Long-acting Hormone Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING HORMONE INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Long-acting Hormone Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Long-acting Hormone Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Long-acting Hormone Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Long-acting Hormone Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Long-acting Hormone Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Long-acting Hormone Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Long-acting Hormone Injection Sales Growth
4.4 APAC Long-acting Hormone Injection Sales Growth
4.5 Europe Long-acting Hormone Injection Sales Growth
4.6 Middle East & Africa Long-acting Hormone Injection Sales Growth
5 AMERICAS
5.1 Americas Long-acting Hormone Injection Sales by Country
5.1.1 Americas Long-acting Hormone Injection Sales by Country (2019-2024)
5.1.2 Americas Long-acting Hormone Injection Revenue by Country (2019-2024)
5.2 Americas Long-acting Hormone Injection Sales by Type (2019-2024)
5.3 Americas Long-acting Hormone Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting Hormone Injection Sales by Region
6.1.1 APAC Long-acting Hormone Injection Sales by Region (2019-2024)
6.1.2 APAC Long-acting Hormone Injection Revenue by Region (2019-2024)
6.2 APAC Long-acting Hormone Injection Sales by Type (2019-2024)
6.3 APAC Long-acting Hormone Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting Hormone Injection by Country
7.1.1 Europe Long-acting Hormone Injection Sales by Country (2019-2024)
7.1.2 Europe Long-acting Hormone Injection Revenue by Country (2019-2024)
7.2 Europe Long-acting Hormone Injection Sales by Type (2019-2024)
7.3 Europe Long-acting Hormone Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting Hormone Injection by Country
8.1.1 Middle East & Africa Long-acting Hormone Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Long-acting Hormone Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Long-acting Hormone Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Long-acting Hormone Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting Hormone Injection
10.3 Manufacturing Process Analysis of Long-acting Hormone Injection
10.4 Industry Chain Structure of Long-acting Hormone Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting Hormone Injection Distributors
11.3 Long-acting Hormone Injection Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING HORMONE INJECTION BY GEOGRAPHIC REGION
12.1 Global Long-acting Hormone Injection Market Size Forecast by Region
12.1.1 Global Long-acting Hormone Injection Forecast by Region (2025-2030)
12.1.2 Global Long-acting Hormone Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Long-acting Hormone Injection Forecast by Type (2025-2030)
12.7 Global Long-acting Hormone Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Long-acting Hormone Injection Product Portfolios and Specifications
13.1.3 Pfizer Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Long-acting Hormone Injection Product Portfolios and Specifications
13.2.3 Bayer Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Organon
13.3.1 Organon Company Information
13.3.2 Organon Long-acting Hormone Injection Product Portfolios and Specifications
13.3.3 Organon Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Organon Main Business Overview
13.3.5 Organon Latest Developments
13.4 Merck & Co. Inc.
13.4.1 Merck & Co. Inc. Company Information
13.4.2 Merck & Co. Inc. Long-acting Hormone Injection Product Portfolios and Specifications
13.4.3 Merck & Co. Inc. Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck & Co. Inc. Main Business Overview
13.4.5 Merck & Co. Inc. Latest Developments
13.5 Adare Pharma Solutions
13.5.1 Adare Pharma Solutions Company Information
13.5.2 Adare Pharma Solutions Long-acting Hormone Injection Product Portfolios and Specifications
13.5.3 Adare Pharma Solutions Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Adare Pharma Solutions Main Business Overview
13.5.5 Adare Pharma Solutions Latest Developments
13.6 Mylan NV
13.6.1 Mylan NV Company Information
13.6.2 Mylan NV Long-acting Hormone Injection Product Portfolios and Specifications
13.6.3 Mylan NV Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Mylan NV Main Business Overview
13.6.5 Mylan NV Latest Developments
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Information
13.7.2 Novo Nordisk Long-acting Hormone Injection Product Portfolios and Specifications
13.7.3 Novo Nordisk Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Novo Nordisk Main Business Overview
13.7.5 Novo Nordisk Latest Developments
13.8 Genentech
13.8.1 Genentech Company Information
13.8.2 Genentech Long-acting Hormone Injection Product Portfolios and Specifications
13.8.3 Genentech Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Genentech Main Business Overview
13.8.5 Genentech Latest Developments
13.9 Eli Lily
13.9.1 Eli Lily Company Information
13.9.2 Eli Lily Long-acting Hormone Injection Product Portfolios and Specifications
13.9.3 Eli Lily Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Eli Lily Main Business Overview
13.9.5 Eli Lily Latest Developments
13.10 Shree Venkatesh International Limited
13.10.1 Shree Venkatesh International Limited Company Information
13.10.2 Shree Venkatesh International Limited Long-acting Hormone Injection Product Portfolios and Specifications
13.10.3 Shree Venkatesh International Limited Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Shree Venkatesh International Limited Main Business Overview
13.10.5 Shree Venkatesh International Limited Latest Developments
13.11 LG Chem
13.11.1 LG Chem Company Information
13.11.2 LG Chem Long-acting Hormone Injection Product Portfolios and Specifications
13.11.3 LG Chem Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 LG Chem Main Business Overview
13.11.5 LG Chem Latest Developments
13.12 Anhui Anke Biotechnology
13.12.1 Anhui Anke Biotechnology Company Information
13.12.2 Anhui Anke Biotechnology Long-acting Hormone Injection Product Portfolios and Specifications
13.12.3 Anhui Anke Biotechnology Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Anhui Anke Biotechnology Main Business Overview
13.12.5 Anhui Anke Biotechnology Latest Developments
13.13 Zhongshan Sinobioway Hygene Biomedicine
13.13.1 Zhongshan Sinobioway Hygene Biomedicine Company Information
13.13.2 Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Portfolios and Specifications
13.13.3 Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Zhongshan Sinobioway Hygene Biomedicine Main Business Overview
13.13.5 Zhongshan Sinobioway Hygene Biomedicine Latest Developments
13.14 Shanghai United Cell Biotechnology
13.14.1 Shanghai United Cell Biotechnology Company Information
13.14.2 Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Portfolios and Specifications
13.14.3 Shanghai United Cell Biotechnology Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Shanghai United Cell Biotechnology Main Business Overview
13.14.5 Shanghai United Cell Biotechnology Latest Developments
13.15 Changchun GeneScience Pharmaceutical
13.15.1 Changchun GeneScience Pharmaceutical Company Information
13.15.2 Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Portfolios and Specifications
13.15.3 Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Changchun GeneScience Pharmaceutical Main Business Overview
13.15.5 Changchun GeneScience Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-acting Hormone Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Long-acting Hormone Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Long-acting Contraceptive Injection
Table 4. Major Players of Growth Hormone Injection
Table 5. Major Players of Others
Table 6. Global Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units)
Table 7. Global Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
Table 8. Global Long-acting Hormone Injection Revenue by Type (2019-2024) & ($ million)
Table 9. Global Long-acting Hormone Injection Revenue Market Share by Type (2019-2024)
Table 10. Global Long-acting Hormone Injection Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Long-acting Hormone Injection Sale by Application (2019-2024) & (K Units)
Table 12. Global Long-acting Hormone Injection Sale Market Share by Application (2019-2024)
Table 13. Global Long-acting Hormone Injection Revenue by Application (2019-2024) & ($ million)
Table 14. Global Long-acting Hormone Injection Revenue Market Share by Application (2019-2024)
Table 15. Global Long-acting Hormone Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Long-acting Hormone Injection Sales by Company (2019-2024) & (K Units)
Table 17. Global Long-acting Hormone Injection Sales Market Share by Company (2019-2024)
Table 18. Global Long-acting Hormone Injection Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Long-acting Hormone Injection Revenue Market Share by Company (2019-2024)
Table 20. Global Long-acting Hormone Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Long-acting Hormone Injection Producing Area Distribution and Sales Area
Table 22. Players Long-acting Hormone Injection Products Offered
Table 23. Long-acting Hormone Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Long-acting Hormone Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Long-acting Hormone Injection Sales Market Share Geographic Region (2019-2024)
Table 28. Global Long-acting Hormone Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Long-acting Hormone Injection Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Long-acting Hormone Injection Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Long-acting Hormone Injection Sales Market Share by Country/Region (2019-2024)
Table 32. Global Long-acting Hormone Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Long-acting Hormone Injection Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units)
Table 35. Americas Long-acting Hormone Injection Sales Market Share by Country (2019-2024)
Table 36. Americas Long-acting Hormone Injection Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units)
Table 38. Americas Long-acting Hormone Injection Sales by Application (2019-2024) & (K Units)
Table 39. APAC Long-acting Hormone Injection Sales by Region (2019-2024) & (K Units)
Table 40. APAC Long-acting Hormone Injection Sales Market Share by Region (2019-2024)
Table 41. APAC Long-acting Hormone Injection Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units)
Table 43. APAC Long-acting Hormone Injection Sales by Application (2019-2024) & (K Units)
Table 44. Europe Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units)
Table 45. Europe Long-acting Hormone Injection Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units)
Table 47. Europe Long-acting Hormone Injection Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Long-acting Hormone Injection Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units)
Table 51. Middle East & Africa Long-acting Hormone Injection Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Long-acting Hormone Injection
Table 53. Key Market Challenges & Risks of Long-acting Hormone Injection
Table 54. Key Industry Trends of Long-acting Hormone Injection
Table 55. Long-acting Hormone Injection Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Long-acting Hormone Injection Distributors List
Table 58. Long-acting Hormone Injection Customer List
Table 59. Global Long-acting Hormone Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global Long-acting Hormone Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Long-acting Hormone Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas Long-acting Hormone Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Long-acting Hormone Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC Long-acting Hormone Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Long-acting Hormone Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe Long-acting Hormone Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Long-acting Hormone Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Long-acting Hormone Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Long-acting Hormone Injection Sales Forecast by Type (2025-2030) & (K Units)
Table 70. Global Long-acting Hormone Injection Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Long-acting Hormone Injection Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global Long-acting Hormone Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Pfizer Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Long-acting Hormone Injection Product Portfolios and Specifications
Table 75. Pfizer Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Bayer Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Bayer Long-acting Hormone Injection Product Portfolios and Specifications
Table 80. Bayer Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Bayer Main Business
Table 82. Bayer Latest Developments
Table 83. Organon Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Organon Long-acting Hormone Injection Product Portfolios and Specifications
Table 85. Organon Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Organon Main Business
Table 87. Organon Latest Developments
Table 88. Merck & Co. Inc. Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck & Co. Inc. Long-acting Hormone Injection Product Portfolios and Specifications
Table 90. Merck & Co. Inc. Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Merck & Co. Inc. Main Business
Table 92. Merck & Co. Inc. Latest Developments
Table 93. Adare Pharma Solutions Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Adare Pharma Solutions Long-acting Hormone Injection Product Portfolios and Specifications
Table 95. Adare Pharma Solutions Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Adare Pharma Solutions Main Business
Table 97. Adare Pharma Solutions Latest Developments
Table 98. Mylan NV Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan NV Long-acting Hormone Injection Product Portfolios and Specifications
Table 100. Mylan NV Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Mylan NV Main Business
Table 102. Mylan NV Latest Developments
Table 103. Novo Nordisk Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Novo Nordisk Long-acting Hormone Injection Product Portfolios and Specifications
Table 105. Novo Nordisk Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Novo Nordisk Main Business
Table 107. Novo Nordisk Latest Developments
Table 108. Genentech Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Genentech Long-acting Hormone Injection Product Portfolios and Specifications
Table 110. Genentech Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Genentech Main Business
Table 112. Genentech Latest Developments
Table 113. Eli Lily Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Eli Lily Long-acting Hormone Injection Product Portfolios and Specifications
Table 115. Eli Lily Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Eli Lily Main Business
Table 117. Eli Lily Latest Developments
Table 118. Shree Venkatesh International Limited Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Shree Venkatesh International Limited Long-acting Hormone Injection Product Portfolios and Specifications
Table 120. Shree Venkatesh International Limited Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Shree Venkatesh International Limited Main Business
Table 122. Shree Venkatesh International Limited Latest Developments
Table 123. LG Chem Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. LG Chem Long-acting Hormone Injection Product Portfolios and Specifications
Table 125. LG Chem Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. LG Chem Main Business
Table 127. LG Chem Latest Developments
Table 128. Anhui Anke Biotechnology Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Anhui Anke Biotechnology Long-acting Hormone Injection Product Portfolios and Specifications
Table 130. Anhui Anke Biotechnology Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Anhui Anke Biotechnology Main Business
Table 132. Anhui Anke Biotechnology Latest Developments
Table 133. Zhongshan Sinobioway Hygene Biomedicine Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Portfolios and Specifications
Table 135. Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Zhongshan Sinobioway Hygene Biomedicine Main Business
Table 137. Zhongshan Sinobioway Hygene Biomedicine Latest Developments
Table 138. Shanghai United Cell Biotechnology Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Portfolios and Specifications
Table 140. Shanghai United Cell Biotechnology Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Shanghai United Cell Biotechnology Main Business
Table 142. Shanghai United Cell Biotechnology Latest Developments
Table 143. Changchun GeneScience Pharmaceutical Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Portfolios and Specifications
Table 145. Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. Changchun GeneScience Pharmaceutical Main Business
Table 147. Changchun GeneScience Pharmaceutical Latest Developments
Table 1. Long-acting Hormone Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Long-acting Hormone Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Long-acting Contraceptive Injection
Table 4. Major Players of Growth Hormone Injection
Table 5. Major Players of Others
Table 6. Global Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units)
Table 7. Global Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
Table 8. Global Long-acting Hormone Injection Revenue by Type (2019-2024) & ($ million)
Table 9. Global Long-acting Hormone Injection Revenue Market Share by Type (2019-2024)
Table 10. Global Long-acting Hormone Injection Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Long-acting Hormone Injection Sale by Application (2019-2024) & (K Units)
Table 12. Global Long-acting Hormone Injection Sale Market Share by Application (2019-2024)
Table 13. Global Long-acting Hormone Injection Revenue by Application (2019-2024) & ($ million)
Table 14. Global Long-acting Hormone Injection Revenue Market Share by Application (2019-2024)
Table 15. Global Long-acting Hormone Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Long-acting Hormone Injection Sales by Company (2019-2024) & (K Units)
Table 17. Global Long-acting Hormone Injection Sales Market Share by Company (2019-2024)
Table 18. Global Long-acting Hormone Injection Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Long-acting Hormone Injection Revenue Market Share by Company (2019-2024)
Table 20. Global Long-acting Hormone Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Long-acting Hormone Injection Producing Area Distribution and Sales Area
Table 22. Players Long-acting Hormone Injection Products Offered
Table 23. Long-acting Hormone Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Long-acting Hormone Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Long-acting Hormone Injection Sales Market Share Geographic Region (2019-2024)
Table 28. Global Long-acting Hormone Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Long-acting Hormone Injection Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Long-acting Hormone Injection Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Long-acting Hormone Injection Sales Market Share by Country/Region (2019-2024)
Table 32. Global Long-acting Hormone Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Long-acting Hormone Injection Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units)
Table 35. Americas Long-acting Hormone Injection Sales Market Share by Country (2019-2024)
Table 36. Americas Long-acting Hormone Injection Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units)
Table 38. Americas Long-acting Hormone Injection Sales by Application (2019-2024) & (K Units)
Table 39. APAC Long-acting Hormone Injection Sales by Region (2019-2024) & (K Units)
Table 40. APAC Long-acting Hormone Injection Sales Market Share by Region (2019-2024)
Table 41. APAC Long-acting Hormone Injection Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units)
Table 43. APAC Long-acting Hormone Injection Sales by Application (2019-2024) & (K Units)
Table 44. Europe Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units)
Table 45. Europe Long-acting Hormone Injection Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units)
Table 47. Europe Long-acting Hormone Injection Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Long-acting Hormone Injection Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Long-acting Hormone Injection Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Long-acting Hormone Injection Sales by Type (2019-2024) & (K Units)
Table 51. Middle East & Africa Long-acting Hormone Injection Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Long-acting Hormone Injection
Table 53. Key Market Challenges & Risks of Long-acting Hormone Injection
Table 54. Key Industry Trends of Long-acting Hormone Injection
Table 55. Long-acting Hormone Injection Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Long-acting Hormone Injection Distributors List
Table 58. Long-acting Hormone Injection Customer List
Table 59. Global Long-acting Hormone Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global Long-acting Hormone Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Long-acting Hormone Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas Long-acting Hormone Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Long-acting Hormone Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC Long-acting Hormone Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Long-acting Hormone Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe Long-acting Hormone Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Long-acting Hormone Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Long-acting Hormone Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Long-acting Hormone Injection Sales Forecast by Type (2025-2030) & (K Units)
Table 70. Global Long-acting Hormone Injection Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Long-acting Hormone Injection Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global Long-acting Hormone Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Pfizer Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 74. Pfizer Long-acting Hormone Injection Product Portfolios and Specifications
Table 75. Pfizer Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Bayer Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Bayer Long-acting Hormone Injection Product Portfolios and Specifications
Table 80. Bayer Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Bayer Main Business
Table 82. Bayer Latest Developments
Table 83. Organon Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Organon Long-acting Hormone Injection Product Portfolios and Specifications
Table 85. Organon Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Organon Main Business
Table 87. Organon Latest Developments
Table 88. Merck & Co. Inc. Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck & Co. Inc. Long-acting Hormone Injection Product Portfolios and Specifications
Table 90. Merck & Co. Inc. Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Merck & Co. Inc. Main Business
Table 92. Merck & Co. Inc. Latest Developments
Table 93. Adare Pharma Solutions Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Adare Pharma Solutions Long-acting Hormone Injection Product Portfolios and Specifications
Table 95. Adare Pharma Solutions Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Adare Pharma Solutions Main Business
Table 97. Adare Pharma Solutions Latest Developments
Table 98. Mylan NV Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Mylan NV Long-acting Hormone Injection Product Portfolios and Specifications
Table 100. Mylan NV Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Mylan NV Main Business
Table 102. Mylan NV Latest Developments
Table 103. Novo Nordisk Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Novo Nordisk Long-acting Hormone Injection Product Portfolios and Specifications
Table 105. Novo Nordisk Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Novo Nordisk Main Business
Table 107. Novo Nordisk Latest Developments
Table 108. Genentech Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Genentech Long-acting Hormone Injection Product Portfolios and Specifications
Table 110. Genentech Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Genentech Main Business
Table 112. Genentech Latest Developments
Table 113. Eli Lily Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Eli Lily Long-acting Hormone Injection Product Portfolios and Specifications
Table 115. Eli Lily Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Eli Lily Main Business
Table 117. Eli Lily Latest Developments
Table 118. Shree Venkatesh International Limited Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Shree Venkatesh International Limited Long-acting Hormone Injection Product Portfolios and Specifications
Table 120. Shree Venkatesh International Limited Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Shree Venkatesh International Limited Main Business
Table 122. Shree Venkatesh International Limited Latest Developments
Table 123. LG Chem Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. LG Chem Long-acting Hormone Injection Product Portfolios and Specifications
Table 125. LG Chem Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. LG Chem Main Business
Table 127. LG Chem Latest Developments
Table 128. Anhui Anke Biotechnology Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Anhui Anke Biotechnology Long-acting Hormone Injection Product Portfolios and Specifications
Table 130. Anhui Anke Biotechnology Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Anhui Anke Biotechnology Main Business
Table 132. Anhui Anke Biotechnology Latest Developments
Table 133. Zhongshan Sinobioway Hygene Biomedicine Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Product Portfolios and Specifications
Table 135. Zhongshan Sinobioway Hygene Biomedicine Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Zhongshan Sinobioway Hygene Biomedicine Main Business
Table 137. Zhongshan Sinobioway Hygene Biomedicine Latest Developments
Table 138. Shanghai United Cell Biotechnology Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Shanghai United Cell Biotechnology Long-acting Hormone Injection Product Portfolios and Specifications
Table 140. Shanghai United Cell Biotechnology Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Shanghai United Cell Biotechnology Main Business
Table 142. Shanghai United Cell Biotechnology Latest Developments
Table 143. Changchun GeneScience Pharmaceutical Basic Information, Long-acting Hormone Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Product Portfolios and Specifications
Table 145. Changchun GeneScience Pharmaceutical Long-acting Hormone Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. Changchun GeneScience Pharmaceutical Main Business
Table 147. Changchun GeneScience Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Long-acting Hormone Injection
Figure 2. Long-acting Hormone Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting Hormone Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Long-acting Hormone Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Long-acting Hormone Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Long-acting Hormone Injection Sales Market Share by Country/Region (2023)
Figure 10. Long-acting Hormone Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Long-acting Contraceptive Injection
Figure 12. Product Picture of Growth Hormone Injection
Figure 13. Product Picture of Others
Figure 14. Global Long-acting Hormone Injection Sales Market Share by Type in 2023
Figure 15. Global Long-acting Hormone Injection Revenue Market Share by Type (2019-2024)
Figure 16. Long-acting Hormone Injection Consumed in Hospital
Figure 17. Global Long-acting Hormone Injection Market: Hospital (2019-2024) & (K Units)
Figure 18. Long-acting Hormone Injection Consumed in Clinic
Figure 19. Global Long-acting Hormone Injection Market: Clinic (2019-2024) & (K Units)
Figure 20. Long-acting Hormone Injection Consumed in Others
Figure 21. Global Long-acting Hormone Injection Market: Others (2019-2024) & (K Units)
Figure 22. Global Long-acting Hormone Injection Sale Market Share by Application (2023)
Figure 23. Global Long-acting Hormone Injection Revenue Market Share by Application in 2023
Figure 24. Long-acting Hormone Injection Sales by Company in 2023 (K Units)
Figure 25. Global Long-acting Hormone Injection Sales Market Share by Company in 2023
Figure 26. Long-acting Hormone Injection Revenue by Company in 2023 ($ millions)
Figure 27. Global Long-acting Hormone Injection Revenue Market Share by Company in 2023
Figure 28. Global Long-acting Hormone Injection Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Long-acting Hormone Injection Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Long-acting Hormone Injection Sales 2019-2024 (K Units)
Figure 31. Americas Long-acting Hormone Injection Revenue 2019-2024 ($ millions)
Figure 32. APAC Long-acting Hormone Injection Sales 2019-2024 (K Units)
Figure 33. APAC Long-acting Hormone Injection Revenue 2019-2024 ($ millions)
Figure 34. Europe Long-acting Hormone Injection Sales 2019-2024 (K Units)
Figure 35. Europe Long-acting Hormone Injection Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Long-acting Hormone Injection Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Long-acting Hormone Injection Revenue 2019-2024 ($ millions)
Figure 38. Americas Long-acting Hormone Injection Sales Market Share by Country in 2023
Figure 39. Americas Long-acting Hormone Injection Revenue Market Share by Country (2019-2024)
Figure 40. Americas Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
Figure 41. Americas Long-acting Hormone Injection Sales Market Share by Application (2019-2024)
Figure 42. United States Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Long-acting Hormone Injection Sales Market Share by Region in 2023
Figure 47. APAC Long-acting Hormone Injection Revenue Market Share by Region (2019-2024)
Figure 48. APAC Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
Figure 49. APAC Long-acting Hormone Injection Sales Market Share by Application (2019-2024)
Figure 50. China Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. India Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 56. China Taiwan Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Long-acting Hormone Injection Sales Market Share by Country in 2023
Figure 58. Europe Long-acting Hormone Injection Revenue Market Share by Country (2019-2024)
Figure 59. Europe Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
Figure 60. Europe Long-acting Hormone Injection Sales Market Share by Application (2019-2024)
Figure 61. Germany Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 62. France Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Long-acting Hormone Injection Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Long-acting Hormone Injection Sales Market Share by Application (2019-2024)
Figure 69. Egypt Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 72. Turkey Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Long-acting Hormone Injection in 2023
Figure 75. Manufacturing Process Analysis of Long-acting Hormone Injection
Figure 76. Industry Chain Structure of Long-acting Hormone Injection
Figure 77. Channels of Distribution
Figure 78. Global Long-acting Hormone Injection Sales Market Forecast by Region (2025-2030)
Figure 79. Global Long-acting Hormone Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Long-acting Hormone Injection Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Long-acting Hormone Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Long-acting Hormone Injection Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Long-acting Hormone Injection Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Long-acting Hormone Injection
Figure 2. Long-acting Hormone Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting Hormone Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Long-acting Hormone Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Long-acting Hormone Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Long-acting Hormone Injection Sales Market Share by Country/Region (2023)
Figure 10. Long-acting Hormone Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Long-acting Contraceptive Injection
Figure 12. Product Picture of Growth Hormone Injection
Figure 13. Product Picture of Others
Figure 14. Global Long-acting Hormone Injection Sales Market Share by Type in 2023
Figure 15. Global Long-acting Hormone Injection Revenue Market Share by Type (2019-2024)
Figure 16. Long-acting Hormone Injection Consumed in Hospital
Figure 17. Global Long-acting Hormone Injection Market: Hospital (2019-2024) & (K Units)
Figure 18. Long-acting Hormone Injection Consumed in Clinic
Figure 19. Global Long-acting Hormone Injection Market: Clinic (2019-2024) & (K Units)
Figure 20. Long-acting Hormone Injection Consumed in Others
Figure 21. Global Long-acting Hormone Injection Market: Others (2019-2024) & (K Units)
Figure 22. Global Long-acting Hormone Injection Sale Market Share by Application (2023)
Figure 23. Global Long-acting Hormone Injection Revenue Market Share by Application in 2023
Figure 24. Long-acting Hormone Injection Sales by Company in 2023 (K Units)
Figure 25. Global Long-acting Hormone Injection Sales Market Share by Company in 2023
Figure 26. Long-acting Hormone Injection Revenue by Company in 2023 ($ millions)
Figure 27. Global Long-acting Hormone Injection Revenue Market Share by Company in 2023
Figure 28. Global Long-acting Hormone Injection Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Long-acting Hormone Injection Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Long-acting Hormone Injection Sales 2019-2024 (K Units)
Figure 31. Americas Long-acting Hormone Injection Revenue 2019-2024 ($ millions)
Figure 32. APAC Long-acting Hormone Injection Sales 2019-2024 (K Units)
Figure 33. APAC Long-acting Hormone Injection Revenue 2019-2024 ($ millions)
Figure 34. Europe Long-acting Hormone Injection Sales 2019-2024 (K Units)
Figure 35. Europe Long-acting Hormone Injection Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Long-acting Hormone Injection Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Long-acting Hormone Injection Revenue 2019-2024 ($ millions)
Figure 38. Americas Long-acting Hormone Injection Sales Market Share by Country in 2023
Figure 39. Americas Long-acting Hormone Injection Revenue Market Share by Country (2019-2024)
Figure 40. Americas Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
Figure 41. Americas Long-acting Hormone Injection Sales Market Share by Application (2019-2024)
Figure 42. United States Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Long-acting Hormone Injection Sales Market Share by Region in 2023
Figure 47. APAC Long-acting Hormone Injection Revenue Market Share by Region (2019-2024)
Figure 48. APAC Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
Figure 49. APAC Long-acting Hormone Injection Sales Market Share by Application (2019-2024)
Figure 50. China Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. India Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 56. China Taiwan Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Long-acting Hormone Injection Sales Market Share by Country in 2023
Figure 58. Europe Long-acting Hormone Injection Revenue Market Share by Country (2019-2024)
Figure 59. Europe Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
Figure 60. Europe Long-acting Hormone Injection Sales Market Share by Application (2019-2024)
Figure 61. Germany Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 62. France Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Long-acting Hormone Injection Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Long-acting Hormone Injection Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Long-acting Hormone Injection Sales Market Share by Application (2019-2024)
Figure 69. Egypt Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 72. Turkey Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Long-acting Hormone Injection Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Long-acting Hormone Injection in 2023
Figure 75. Manufacturing Process Analysis of Long-acting Hormone Injection
Figure 76. Industry Chain Structure of Long-acting Hormone Injection
Figure 77. Channels of Distribution
Figure 78. Global Long-acting Hormone Injection Sales Market Forecast by Region (2025-2030)
Figure 79. Global Long-acting Hormone Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Long-acting Hormone Injection Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Long-acting Hormone Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Long-acting Hormone Injection Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Long-acting Hormone Injection Revenue Market Share Forecast by Application (2025-2030)
